2Seventy Bio Inc(TSVT)

5.00+0.000.00%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
- BMS 2.86亿美元收购2seventy，蓝鸟彻底“坠落”
  新浪医药 · 2025-03-11
  BMS 2.86亿美元收购2seventy，蓝鸟彻底“坠落”
- 盘前异动 | CAR-T细胞疗法公司2Seventy涨近80%，获施贵宝溢价收购
  老虎资讯综合 · 2025-03-11
  盘前异动 | CAR-T细胞疗法公司2Seventy涨近80%，获施贵宝溢价收购
- BMS收购CAR-T细胞疗法公司2seventy bio
  医药魔方 · 2025-03-11
  BMS收购CAR-T细胞疗法公司2seventy bio
- 2Seventy Bio, Inc.盘中异动股价大涨6.02%报2.82美元
  市场透视 · 2025-03-11
  2Seventy Bio, Inc.盘中异动股价大涨6.02%报2.82美元
- 2Seventy Bio, Inc.盘中异动早盘股价大涨5.38%报2.74美元
  市场透视 · 2025-03-05
  2Seventy Bio, Inc.盘中异动早盘股价大涨5.38%报2.74美元
- 2Seventy Bio, Inc.盘中异动大幅拉升5.24%报2.61美元
  市场透视 · 2025-03-05
  2Seventy Bio, Inc.盘中异动大幅拉升5.24%报2.61美元
- 2Seventy Bio, Inc.盘中异动股价大跌5.30%
  市场透视 · 2025-03-04
  2Seventy Bio, Inc.盘中异动股价大跌5.30%
- 2Seventy Bio, Inc.盘中异动临近收盘急速拉升5.20%报2.63美元
  市场透视 · 2025-03-01
  2Seventy Bio, Inc.盘中异动临近收盘急速拉升5.20%报2.63美元
- 2Seventy Bio, Inc.盘中异动急速上涨6.51%
  市场透视 · 2025-02-25
  2Seventy Bio, Inc.盘中异动急速上涨6.51%
- 2Seventy Bio, Inc.盘中异动股价大跌5.31%
  市场透视 · 2025-02-19
  2Seventy Bio, Inc.盘中异动股价大跌5.31%
- 2Seventy Bio, Inc.盘中异动股价大涨5.02%报2.51美元
  市场透视 · 2025-02-14
  2Seventy Bio, Inc.盘中异动股价大涨5.02%报2.51美元
- 2Seventy Bio, Inc.盘中异动急速上涨5.22%
  市场透视 · 2025-02-10
  2Seventy Bio, Inc.盘中异动急速上涨5.22%
- 2Seventy Bio, Inc.盘中异动早盘急速跳水5.04%
  市场透视 · 2025-02-08
  2Seventy Bio, Inc.盘中异动早盘急速跳水5.04%
- 2Seventy Bio, Inc.盘中异动早盘股价大跌5.11%报2.60美元
  市场透视 · 2025-02-06
  2Seventy Bio, Inc.盘中异动早盘股价大跌5.11%报2.60美元
- 2Seventy Bio, Inc.盘中异动快速拉升5.02%
  市场透视 · 2025-02-04
  2Seventy Bio, Inc.盘中异动快速拉升5.02%
- 2Seventy Bio, Inc.盘中异动急速下跌5.08%
  市场透视 · 2025-02-03
  2Seventy Bio, Inc.盘中异动急速下跌5.08%
- 2Seventy Bio, Inc.盘中异动早盘股价大涨5.34%
  市场透视 · 2025-01-31
  2Seventy Bio, Inc.盘中异动早盘股价大涨5.34%
- 2Seventy Bio, Inc.盘中异动大幅拉升5.22%
  市场透视 · 2025-01-31
  2Seventy Bio, Inc.盘中异动大幅拉升5.22%
- 2Seventy Bio, Inc.盘中异动早盘股价大涨5.00%
  市场透视 · 2025-01-27
  2Seventy Bio, Inc.盘中异动早盘股价大涨5.00%
- 2Seventy Bio, Inc.盘中异动早盘急速上涨5.18%报2.64美元
  市场透视 · 2025-01-24
  2Seventy Bio, Inc.盘中异动早盘急速上涨5.18%报2.64美元
公司概况
公司名称
2Seventy Bio Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.2seventybio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
2seventy bio, Inc.于2021年4月26日在特拉华州注册成立。该公司是一家细胞和基因治疗公司，专注于癌症转化疗法的研究、开发和商业化。该公司正在推进肿瘤学的多个临床前和临床项目，并与他们的合作伙伴百时美施贵宝(BMS)一起，在批准接受至少四种先前治疗的多发性骨髓瘤患者后，向美国的多发性骨髓瘤患者提供Abecma，包括免疫调节剂、蛋白酶体抑制剂和抗CD38单克隆抗体。
- 2025-05-13
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13
  员工持股计划
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
  Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
- 2025-05-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-05-13
  交易所摘牌声明
  Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
  Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
- 2025-05-07
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 2025-05-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-04-28
  [修订]年度报告
  Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
  Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
- 2025-03-25
  年度报告
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
  Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
- 2025-03-25
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-03-11
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-02-06
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2025-01-10
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 2024-12-13
  关联方拟减持公告
  Form 144 - Report of proposed sale of securities
  Form 144 - Report of proposed sale of securities

分时
5日
日
周
月

数据加载中...

最高

5.00

今开

5.00

量比

0.00

最低

5.00

昨收

5.00

换手率

0.00%

2Seventy Bio Inc(TSVT)

公司概况

热议股票